LEXINGTON, Ky. (WDKY) – We could know by the end of the day if the FDA will approve a third vaccine to be used in the fight against COVID-19.
Three Kentucky hospitals played a big role in the clinical trials of that vaccine.
The Johnson and Johnson vaccine is a one-dose shot, unlike vaccines we currently have that require an initial shot and a booster. The FDA is reviewing it for potential emergency use authorization.
UK Healthcare, Baptist Health Lexington, and Norton Healthcare in Louisville took part in the phase 3 trial of that vaccine. There are almost 900 volunteers locally and more than 43,000 across the world.
Their results show the vaccine was 86% effective against severe COVID-19 illness and had a 66% efficacy rate overall.
Another big advantage is that this vaccine could be kept in a regular refrigerator for up to three months. So, for more rural areas that may not have specially refrigerated, this could be an option.
We’ll keep you updated.